APPLICATIONS PUBLISHED 17 APRIL 2002
Published: 1-Nov-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue
The University of Utah Research Foundation 1196088*
Method for releasing an agent from a red blood cell
Gendel 1196143*
A liposome compsn having resistance to freeze-thaw damage
Alza Corp 1196144*
Method and apparatus for preparation of lipid vesicles
Inex Pharmaceuticals 1196145*
Powder particles with smooth surface for use in inhalation therapy
Chiesi Farmaceutici 1196146*
Oral liquid compsns
aalPharma; Wilson, Edward S; Trespidi, Laura A; Clark, Christy M; Desai, Ashok J; Meyer, Glenn A 1196147*
Process for microencapsulation of water soluble substances
Debio Recherche Pharmaceutique 1196148*
Biodegradable poly(alkene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery compsn comprising same
Samyang Corp 1196149*
Silver-containing, sol-gel derived bioglass compsns
Imperial College Innovations 1196150*
Transdermal therapeutic system for administering a calcium antagonist
LTS Lohmann Therapie-Systeme 1196151*
Use of cortisol antagonists in the treatment of congestive heart failure
Cortendo 1196152*
Process for the improvement of spermatozoa fertilisation activity
Applied Research Systems 1196153*
Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine
Mallinckrodt 1196154*
New use of compounds as antibacterial agents
AstraZeneca 1196155*
Transnasal anticonvulsive compsns and modulated process
SK Corporation 1196156*
Amphiphilic drug-oligomer conjugates with hydrolysable lipophile components and methods for making and using the same
Nobex Corp 1196158*
Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
Rapp, Horst 1196159*
A synergistic combination: gabapentin and pregabalin
Warner-Lambert Company 1196160*
Selective inhibition of cyclooxygenase-2
Wisconsin Alumni Research Foundation 1196161*
Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective compsn of same
LG Chemical 1196162*
Methods of treating an/or suppressing weight gain
Endorecherche 1196163*
Methods and compsns for regulating gut motility and food intake
Enpharma 1196164*
Azetidine compounds in CNS and eye diseases
Vernalis Research 1196165*
Azetidine carboxamide derivatives for the treatment of CNS disorders
Vernalis Research 1196166*
Method of reducing neuronal injury or apoptosis
Lipton, Stuart A 1196167*
Method of administering an imidazole derivative to obtain analgesia
Orion 1196168*
Compounds having cytokine inhibitory activity
Merck 1196169*
New use for a macrolide compound for treating neurodegenerative disorders
Fujisawa Pharmaceutical 1196170*
Use of pyridoxin derivatives for the treatment of diabetes and related complications
Medicure 1196171*
Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders
Pharmacia & Upjohn 1196172*
Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof
Bayer 1196173*
Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
Wisconsin Alumni Research Foundation 1196174*
Pharmaceutical tablets
Merck 1196175*
Use of beta-naphthaquinone for making medicines having an inhibiting effect on the release of glutamate by the brain
Centre National de la Recherche Scientifique 1196176*
Use of ouabain and ouabain-like molecules in apoptosis related pathologies
Corporation du Centre de Recherche du Hospitalier de l'universite de Montreal 1196177*
Covalently closed immunostimulating nucleic acid molecule
Mologen Forschungs-, Entwicklungs- and Vertriebs 1196178*
Hyaluronic acid derivatives for the prevention and treatment of cutaneous scars
Fidia Advanced Biopolymers 1196179*
Treatment of angiogenesis dependent conditions with dextrin sulphate
ML Laboratories 1196180*
Treatment of angiogenesis dependent conditions with dextrin sulphate
ML Laboratories 1196180*
Fat-binding polymers, optionally combined with lipase inhibitors
Geltex Pharmaceuticals 1196181*
Oregano-based therapeutic compsn
Papaprodomou, Andreas 1196183*
Compsns and methods for treatment of sexual dysfunction
Palatin Technologies 1196184*
Novel use of hypo-osmotic saline solutions and medicine based on said solutions
Laboratoires Goemar 1196185*
Promotion or inhibition of angiogenesis and cardiovascularisation by tumour necrosis factor/ligand receptor homologs
Genentech 1196186*
Keratinocyte growth factor-2 formulations
Human Genome Sciences 1196187*
Multiple agent diabetes therapy
Medtronic 1196189*
Use of long-chain N-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases
GD Searle 1196190*
